Thank you.
To change topics a little bit, there is something that Sweden has in common with Canada. Right now, Sweden has one of Europe's largest elderly populations. This, of course, is expected to continue as birth rates are dropping. Canada has much the same issue. Our population is aging, and we're seeing the diseases that come with age. We're expecting increased health challenges and costs.
First of all, can you tell me if there are any preparations for how Sweden's system for pharmaceuticals and the health care system in general are going to manage these costs?